SAMHSA [3/27] | In a letter to clinicians, SAMHSA wrote that xylazine is an emerging public health threat and noted that routine toxicology tests do not test for the substance. Cont.
top of page
Search
Recent Posts
See AllSAMHSA [12/19] – SAMHSA has issued a new Practical Guide: Advising People on Using 988 Versus 911 to help in better understanding the...
SAMHSA [12/18] – SAMHSA recently published five documents to promote the integration and advancement of promising practices in SUD...
NIDA [12/17] – After declining significantly during the COVID-19 pandemic, substance use among adolescents has continued to hold steady...
bottom of page
Comentários